Obesogenic high-fat diet heightens aerobic glycolysis through hyperactivation of oncogenic KRAS
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-811X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Obesogenic high-fat diet heightens aerobic glycolysis through hyperactivation of oncogenic KRAS ; volume:17 ; number:1 ; day:28 ; month:2 ; year:2019 ; pages:1-9 ; date:12.2019
Cell communication and signaling ; 17, Heft 1 (28.2.2019), 1-9, 12.2019
- Urheber
-
Wang, Dan
Bi, Yawei
Hu, Lianghao
Luo, Yongde
Ji, Juntao
Mao, Albert Z.
Logsdon, Craig D.
Li, Ellen
Abbruzzese, James L.
Li, Zhaoshen
Yang, Vincent W.
Lu, Weiqin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-019-0333-7
- URN
-
urn:nbn:de:101:1-2019032600350235384755
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Dan
- Bi, Yawei
- Hu, Lianghao
- Luo, Yongde
- Ji, Juntao
- Mao, Albert Z.
- Logsdon, Craig D.
- Li, Ellen
- Abbruzzese, James L.
- Li, Zhaoshen
- Yang, Vincent W.
- Lu, Weiqin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Proton export upregulates aerobic glycolysis
Oncogenic TRIB2 interacts with and regulates PKM2 to promote aerobic glycolysis and lung cancer cell procession
Immune modulatory effects of oncogenic KRAS in cancer
Oncogenic KRAS promotes malignant brain tumors in zebrafish
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges
FLIPL is critical for aerobic glycolysis in hepatocellular carcinoma
Catabolic efficiency of aerobic glycolysis: The Warburg effect revisited
RFC2 promotes aerobic glycolysis and progression of colorectal cancer
Oncogenic KRAS renders cells resistant to ferroptosis by upregulating FSP1
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Controlling oncogenic KRAS signaling pathways with a Palladium-responsive peptide
Proton export upregulates aerobic glycolysis
Oncogenic TRIB2 interacts with and regulates PKM2 to promote aerobic glycolysis and lung cancer cell procession
Immune modulatory effects of oncogenic KRAS in cancer
Oncogenic KRAS promotes malignant brain tumors in zebrafish
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges
FLIPL is critical for aerobic glycolysis in hepatocellular carcinoma
Catabolic efficiency of aerobic glycolysis: The Warburg effect revisited
RFC2 promotes aerobic glycolysis and progression of colorectal cancer
Oncogenic KRAS renders cells resistant to ferroptosis by upregulating FSP1
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Controlling oncogenic KRAS signaling pathways with a Palladium-responsive peptide
Proton export upregulates aerobic glycolysis
Oncogenic TRIB2 interacts with and regulates PKM2 to promote aerobic glycolysis and lung cancer cell procession
Immune modulatory effects of oncogenic KRAS in cancer
Oncogenic KRAS promotes malignant brain tumors in zebrafish
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges
FLIPL is critical for aerobic glycolysis in hepatocellular carcinoma
Catabolic efficiency of aerobic glycolysis: The Warburg effect revisited
RFC2 promotes aerobic glycolysis and progression of colorectal cancer
Oncogenic KRAS renders cells resistant to ferroptosis by upregulating FSP1
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis